Le Lézard
Classified in: Environment, Health, Covid-19 virus
Subjects: SVY, CFG

Government of Canada launches consultations on the development of the Pan-Canadian Genomics Strategy


Public feedback will inform plan to position Canada for success in the bioeconomy

OTTAWA, ON, May 24, 2022 /CNW/ - Over the past years, Canada has built renowned world-class strength in genomics research. This, along with our strong public health care system, diverse ecosystems, and abundant natural resources and food sectors, has positioned Canada as a leader in genomics technologies and innovations.

Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, announced the launch of public consultations for the upcoming Pan-Canadian Genomics Strategy. The consultations will provide the government with valuable insights on the development of a strategy aimed to enhance federal investments in genomics and advance the commercialization and adoption of genomics to cement Canada's position as a leader in research and innovation.

Canadians are invited to review the consultation paper and to provide input through an online survey. The government will also host targeted roundtables with stakeholders across academia, not-for-profit organizations and the private sector. The online consultations and the roundtable discussions are running from now through to June 24. A summary report of the findings will be published later this year.

Genomics is the science that aims to help us better understand the entire set of genetic information encoded in DNA and related molecules. Also, genomics has played a significant role in helping Canada fight against the COVID-19 pandemic (e.g. tracking and sequencing, diagnostic devices, and mRNA vaccines and therapeutics) and is instrumental in addressing climate change, food and energy security, precision health, environmental protection and economic recovery.

Quotes

"The Government of Canada recognizes that genomics is a key technology instrumental in responding to the national and global challenges of our time. This is why our future Pan-Canadian Genomics Strategy will help cement Canada as a leader in genomics research and commercialize our genomics innovations and technologies, all while creating many important benefits for Canadians and positioning Canada for long-term success in the bioeconomy."
? The Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry

Quick facts
Related products
Stay connected

Find more services and information at Canada.ca/ISED.

Follow Innovation, Science and Economic Development Canada on social media.
Twitter: @ISED_CA, Facebook: Canadian Innovation, Instagram: @cdninnovation and LinkedIn

SOURCE Innovation, Science and Economic Development Canada


These press releases may also interest you

at 03:05
Vagaro, the leading international salon and spa software, and Jack Mead, award-winning hair stylist, salon owner, and educator, officially announced the release of their highly-anticipated Master Class series, delivering expert insights on using the...

at 02:30
Allied Market Research published a report, titled, "Pension Administration Software Market by Component (Solution and Services), Deployment Mode (On-Premise and Cloud), Type (Public Pension and Private Pension), End User (Employers, Pension Plan...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:05
Teck Resources Limited (Teck) today announced its unaudited first quarter results for 2024. "All outstanding major construction at our QB operation was completed in the first quarter, including the shiploader and molybdenum plant, and we marked the...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: